Slezska nemocnice v Opave prispevkova organizace

The medical center is at the forefront of prostate cancer research, focusing on innovative treatments for high-risk cases. The ongoing studies aim to enhance the efficacy and safety of therapeutic interventions, particularly in patients receiving primary radiation therapy.

• High-risk localized prostate cancer
• Locally advanced prostate cancer
• Primary radiation therapy advancements

Through its research, the center is contributing to significant advancements in the management of prostate cancer, particularly by exploring the combination of apalutamide with GnRH agonists to improve metastasis-free survival (MFS) as evaluated by advanced imaging techniques.